covid vaccines covid vaccines
Stories About

covid vaccines

Thursday

A new round of COVID-19 vaccines will be rolled out soon. Scott Olson/Getty Images hide caption

toggle caption
Scott Olson/Getty Images

New COVID Vaccines

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5082372/nx-s1-ef6edc0b-f1c0-431b-82d8-040da8d937d7" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

Monday

Secretary-General of the Nobel Assembly Thomas Perlmann speaks in front of a picture of Katalin Karikó and Drew Weissman, winners of the 2023 Nobel Prize in Physiology or Medicine, at the Karolinska Institute in Stockholm on Monday. JONATHAN NACKSTRAND/AFP via Getty Images hide caption

toggle caption
JONATHAN NACKSTRAND/AFP via Getty Images

Nobel Prize goes to scientists who made mRNA COVID vaccines possible

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1202941256/1202954113" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Experts say the new COVID boosters are a much closer match to currently circulating variants than prior vaccines and boosters. Frederick J. Brown/AFP via Getty Images hide caption

toggle caption
Frederick J. Brown/AFP via Getty Images

The new COVID boosters are coming: Here's what you need to know

  • Download
  • <iframe src="https://www.npr.org/player/embed/1198803134/1199473208" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Monday

Another round of COVID-19 vaccines is on the way. The Food and Drug Administration approved vaccines from Pfizer and Moderna that target an omicron subvariant called XBB.1.5. Vaccination campaigns, like this one in San Rafael, Calif., in 2022, could resume soon. Justin Sullivan/Getty Images hide caption

toggle caption
Justin Sullivan/Getty Images

New COVID vaccines get FDA approval

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1198719166/1198805527" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Even though the uptake of the omicron booster has been lackluster, federal officials have decided some adults can get a second shot. Scott Olson/Getty Images hide caption

toggle caption
Scott Olson/Getty Images

Some adults can now get a second shot of the bivalent COVID-19 vaccine

  • Download
  • <iframe src="https://www.npr.org/player/embed/1166629853/1166788630" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Friday

An older adult receives a COVID-19 vaccine at a temporary vaccination site on Dec. 7 in Chongqing, China. Concerns about effectiveness and safety have led to uncertainty about the COVID vaccine, notably among older citizens, whose vaccination rate is relatively low. He Penglei/China News Service via Getty Images hide caption

toggle caption
He Penglei/China News Service via Getty Images

China's COVID vaccines: Do the jabs do the job?

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1143696652/1146494894" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Bivalent COVID-19 vaccines are readied for use at a clinic in Richmond, Va., Nov. 2022. Just 15% of eligible Americans have gotten the most recent booster shot, according to the CDC. Steve Helber/AP hide caption

toggle caption
Steve Helber/AP

It's not too late to get a COVID booster — especially for older adults

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1145339626/1146543204" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

Travelers at Shanghai Hongqiao Railway Station in Shanghai, China on Dec. 12. China's public health officials say up to 800 million people could be infected with the coronavirus over the next few months. Qilai Shen/Bloomberg via Getty Images hide caption

toggle caption
Qilai Shen/Bloomberg via Getty Images

COVID spreading faster than ever in China. 800 million could be infected this winter

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1143002538/1143002539" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

Tuesday

The new COVID boosters rolling out this month represent a shift in strategy, said White House COVID-19 Response Coordinator Dr. Ashish Jha during a press briefing. The goal now will likely be to roll out new boosters annually. Anna Moneymaker/Getty Images hide caption

toggle caption
Anna Moneymaker/Getty Images

The new COVID booster could be the last you'll need for a year, federal officials say

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1121289835/1121346549" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Vials of the newly reformulated COVID-19 vaccine booster are being readied by Pfizer for distribution now that the Food and Drug Administration has authorized the shots for people 12 and older. Pfizer Inc. hide caption

toggle caption
Pfizer Inc.

Friday

Thursday

Patricia Neves (left) and Ana Paula Ano Bom helped launch a global project to revolutionize access to mRNA technology. Ian Cheibub for NPR hide caption

toggle caption
Ian Cheibub for NPR

Tuesday

A kidney dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use in February at a vaccination center in Prisdorf, Germany. Georg Wendt/AP hide caption

toggle caption
Georg Wendt/AP